Who is eligible for TIL therapy for melanoma?

Connect with the MRF online:
------------------------------------------------------------------------------------------------
Video description:
Rekha Chaudhary, MD, a hematologist and oncologist who specializes in the treatment of melanoma at the University of Cincinnati, explains some of the important criteria that make a melanoma patient eligible for tumor infiltrating lymphocyte (TIL) therapy. Patients need a tumor large enough and accessible enough to biopsy for TIL therapy. They also need to be healthy enough to undergo the chemotherapy, or lymphodepletion, as well as the IL-2 infusions to receive the TIL therapy.